Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IV Study to Assess the Safety of Menveo Vaccine Being Used by HMO Subjects Aged 11-21 Years of Age

NCT01452464 is registered in ClinicalTrials.gov with Novartis Vaccines as lead sponsor.

NCT NCT01452464
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01452464 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IV Study to Assess the Safety of Menveo Vaccine Being Used by HMO Subjects Aged 11-21 Years of Age
Lead sponsor
Novartis Vaccines
Phase
Observational
Overall status
Completed
Start date
September 30, 2011
Completion date
February 28, 2015
Enrollment
55,397 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

meningococcal disease